Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia

Brian J. Druker, Nicholas B. Lydon

Research output: Contribution to journal › Review article › peer-review

824 Scopus citations

Fingerprint

Dive into the research topics of 'Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia'. Together they form a unique fingerprint.